Compounds > berberine
Page last updated: 2024-10-23

berberine and Chronic Pancreatitis

berberine has been researched along with Chronic Pancreatitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Berberine (BR) acts as an AMP-activated protein kinase (AMPK) activator which possesses antioxidant and anti-inflammatory properties."5.56Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. ( Bansod, S; Doijad, N; Godugu, C, 2020)
"Berberine (BR) acts as an AMP-activated protein kinase (AMPK) activator which possesses antioxidant and anti-inflammatory properties."1.56Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. ( Bansod, S; Doijad, N; Godugu, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bansod, S1
Doijad, N1
Godugu, C1

Other Studies

1 other study available for berberine and Chronic Pancreatitis

ArticleYear
Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization.
    Toxicology and applied pharmacology, 2020, 09-15, Volume: 403

    Topics: Actins; AMP-Activated Protein Kinase Kinases; Animals; Berberine; Ceruletide; Collagen Type I; Extra

2020